Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04247126
Title A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Syros Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
Orlando Health Cancer Institute Orlando Florida 32806 United States Details
Emory University Atlanta Georgia 30322 United States Details
The University of Iowa Iowa City Iowa 52242 United States Details
Johns Hopkins University Baltimore Maryland 21205 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
START Midwest, LLC Grand Rapids Michigan 49546 United States Details
Duke University Durham North Carolina 27705 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute - Tennessee Oncology Nashville Tennessee 37203 United States Details
South Texas Accelerated Research Theraputics (START), LLC San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field